Rare diseases
Investigational molecules
Locations
Back to France1 156 clinical trials in Bordeaux, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy
FranceStudy of Olaparib for Patients with Advanced BRCA-Mutated Ovarian Cancer After Initial Platinum-Based Chemotherapy
FranceStudy on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB
FranceStudy on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata
FranceStudy of tucatinib, pertuzumab and trastuzumab combination for patients with HER2-positive metastatic breast cancer who have brain metastases after local therapy
FranceComparing Methotrexate and Tocilizumab for Treating Giant Cell Arteritis in Patients: A Study on Effectiveness and Safety
FranceStudy of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment
FranceComparing drug combinations with panitumumab for patients with RAS and B-RAF wild-type metastatic colorectal cancer
FranceStudy of DF6002 alone and combined with nivolumab in patients with advanced solid tumors: A safety and effectiveness trial
FranceStudy on the Safety and Effects of IPH6501 for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
FranceStudy on the Effectiveness and Safety of Ravulizumab for Children and Adolescents with Neuromyelitis Optica Spectrum Disorder (NMOSD)
FranceStudy on Chemotherapy with Paclitaxel, Cisplatin, and Carboplatin for Patients with Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on psoriatic arthritis and hidradenitis suppurativa, evaluating new therapeutic combinations and treatment strategies. Studies explore the effectiveness of targeted therapies and novel approaches like fecal microbiota transplantation.
Clinical trials aim to improve patient outcomes through combination therapies and innovative treatment approaches.
Comprehensive studies investigating treatments for various cancers, including head and neck squamous cell carcinoma, endometrial cancer, and bladder cancer. Research focuses on immunotherapy combinations and targeted treatments.
Trials evaluate novel drug combinations and therapeutic approaches for better cancer treatment outcomes.
Ground-breaking research in kidney transplantation, focusing on preventing rejection and improving long-term outcomes. Studies evaluate new immunosuppressive strategies and antibody-mediated rejection treatments.
Research aims to enhance transplant success rates and patient quality of life.
Studies examining multiple sclerosis, narcolepsy, and major depressive disorder. Research investigates neuroinflammation patterns and innovative treatment approaches.
Trials focus on understanding disease mechanisms and developing targeted therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
